Kazia Therapeutics Limited (KZIA) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Kazia Therapeutics Limite...

    NASDAQ: KZIA · Real-Time Price · USD
    6.56
    0.25 (3.96%)
    At close: Oct 03, 2025, 3:59 PM
    6.42
    -2.14%
    After-hours: Oct 03, 2025, 07:51 PM EDT

    Kazia Therapeutics Cash Flow Statement

    Financials in AUD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
    Net Income
    		 -26.78M -20.46M -24.65M -8.42M
    Depreciation & Amortization
    		 1.87M 1.87M 1.95M 1.27M
    Stock-Based Compensation
    		 533K 1.16M 1.68M 637K
    Other Working Capital
    		 10M 584.09K -98K -1.09M
    Other Non-Cash Items
    		 4.79M -1.75M -1.64M -864.66K
    Deferred Income Tax
    		 n/a n/a n/a 4.39M
    Change in Working Capital
    		 10M 4.03M -104K -6.12M
    Operating Cash Flow
    		 -9.58M -15.16M -22.76M -9.11M
    Capital Expenditures
    		 n/a n/a n/a n/a
    Cash Acquisitions
    		 n/a n/a -2.37M n/a
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a 268.00 n/a
    Investing Cash Flow
    		 n/a n/a -2.36M n/a
    Debt Repayment
    		 405K n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a -3 187.00 -152
    Financial Cash Flow
    		 5.99M 12.97M 3.73M 28.11M
    Net Cash Flow
    		 -3.58M -2.12M -20.23M 18.82M
    Free Cash Flow
    		 -9.58M -15.16M -22.76M -9.11M

    Add to Watchlist